H&Q Life Sciences Investors (HQL)
-NYSE 18.82 
0.07(0.37%) May 24, 4:00PM EDT
| Prev Close: | 18.89 |
|---|
| Open: | 18.61 |
|---|
| Bid: | 17.07 x 100 |
|---|
| Ask: | 18.83 x 400 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 0.94 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 18.61 - 18.90 |
|---|
| 52wk Range: | 12.86 - 21.00 |
|---|
| Volume: | 28,450 |
|---|
| Avg Vol (3m): | 62,772 |
|---|
| Market Cap: | 271.53M |
|---|
| P/E (ttm): | 3.50 |
|---|
| EPS (ttm): | 5.38 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- CORRECTING and REPLACING H&Q Life Sciences Investors Declares Stock DistributionBusiness Wire(Wed, May 22)
- H&Q Life Sciences Investors Pays Stock DistributionBusiness Wire(Mon, Apr 1)
- H&Q LIFE SCIENCES INVESTORS Files SEC form 8-K, Other EventsEDGAR Online(Mon, Mar 25)
- H&Q Life Sciences Investors Announces Renewal of Share Repurchase ProgramBusiness Wire(Fri, Mar 22)
- H&Q Life Sciences Investors Declares Stock DistributionBusiness Wire(Tue, Feb 19)
- H&Q Life Sciences Investors Pays Stock DistributionBusiness Wire(Wed, Jan 2)
- The CEF Sell-Off: Time To Buy?at Seeking Alpha(Sat, Nov 17)
- H&Q Life Sciences Investors Declares Stock DistributionBusiness Wire(Wed, Nov 7)
- 3 Retirement Picks: Sleep Easier, 10% + Returns For 10 Yearsat Seeking Alpha(Fri, Sep 28)
- IlluminOss Medical Secures $28 Million Series C Financing for Minimally Invasive Bone Fracture RepairMarketwired(Thu, Sep 27)
- 3 Low-Debt, High Yield Financial Dividends Raking In Profitsat Seeking Alpha(Wed, Aug 22)
- CEF Weekly Review: IDE Goes Ex-Dividend Mondayat Seeking Alpha(Sun, Jul 1)
- Three Keys to Finding Good Dividend Stocksat Minyanville(Wed, Jun 6)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 127.09 |
|---|
| Ex-Dividend Date: | 27-Feb-13 |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
H&Q Life Sciences Investors is a close ended equity mutual fund launched and managed by Hambrecht & Quist Capital Management, LLC. The fund invests in the public equity markets across the globe.
View More